Literature DB >> 16075787

Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma--a paradigm shift.

Howard A Fine1.   

Abstract

Entities:  

Year:  2005        PMID： 16075787     DOI： 10.1038/ncponc0204

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  2 in total

1.  Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Authors:  Paul D Brown; Sunil Krishnan; Jann N Sarkaria; Wenting Wu; Kurt A Jaeckle; Joon H Uhm; Francois J Geoffroy; Robert Arusell; Gaspar Kitange; Robert B Jenkins; John W Kugler; Roscoe F Morton; Kendrith M Rowland; Paul Mischel; William H Yong; Bernd W Scheithauer; David Schiff; Caterina Giannini; Jan C Buckner
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

2.  D-Mannose Slows Glioma Growth by Modulating Myeloperoxidase Activity.

Authors:  Negin Jalali Motlagh; Cuihua Wang; Enrico Giovanni Kuellenberg; Gregory R Wojtkiewicz; Stephan Schmidt; John W Chen
Journal:  Cancers (Basel)       Date:  2021-12-18       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.